Original articles

The discrepancy of thrombin time results between two kinds of thrombolyzer in a patient associated with heparin like anticoagulant

Expand
  • Yangzhou University College of Clinical Medicine, Northern Jiangsu's People's Hospital, Jiangsu Yangzhou 225001, China

Received date: 2018-05-24

  Online published: 2018-12-25

Abstract

Objective: To explore the cause of discrepancy in results of thrombin time(TT) between two kinds of thrombolyzer in a 4-year-old male child with glandular hypertrophy. Methods: A series of plasma samples were obtained during 7 months follow-up periods, one stage clotting assay was used for coagulation factors tests, protamine sulfate neutralization test was performed, and three fibrinogen genes were sequenced. Results: The significant difference in TT results between thrombolyzer A (magenetic beads) and B (transmission turbidimetry) was further confirmed by two reference labs with a prolonged TT in A and normal TT in B. Activated partial thromboplastin time (APTT) were 52.4 s and 36.6 s, TT were 88.7 s and 16.7 s by A and B thrombolyzer, respectively. The prolonged TT was corrected by 50 μg/ml (final concentration) protamine sulfate, and the reptilase time was normal. No mutation was found in fibrinogen genes by gene analysis. Thus, the presence of endogenous heparin like anticoagulant in this boy was confirmed. Conclusions: Endogenous heparin like anticoagulant is rare and existed in this boy, causing the discrepancy of TT results between the two kinds of thrombokyzer. Therefore, if a discrepancy of TT results is found, other causes such as heparin like anticoagulant should be considered.

Cite this article

XU Mengyang, HE Bin, HUA Baolai, JI Wei, SHEN Lianjun, SHI Qingqing, SUN Xing, YU Ju, XIE Xiaoyan, SUN Mei, GU Jian . The discrepancy of thrombin time results between two kinds of thrombolyzer in a patient associated with heparin like anticoagulant[J]. Journal of Diagnostics Concepts & Practice, 2018 , 17(06) : 707 -710 . DOI: 10.16150/j.1671-2870.2018.06.015

References

[1] Lasser EC, Simon RA, Lyon SG,et al.Heparin-like anticoagulants in asthma[J]. Allergy,1987,42(8):619-625.
[2] 王书杰, 赵永强. 获得性凝血抑制物[M].2版//张之南. 血液病学. 北京: 人民卫生出版社,2017:1324-1337.
[3] Torjemane L, Guermazi S, Ladeb S, et al.Heparin-like anticoagulant associated with multiple myeloma and neutralized with protamine sulfate[J]. Blood Coagul Fibrinolysis,2007,18(3):279-281.
[4] Durila M, Pavlicek P, Hadacova I, et al.Endogenous Heparinoids May Cause Bleeding in Mucor Infection and can be Detected by Nonactivated Thromboelastometry and Treated by Recombinant Activated Factor VII: A Case Report[J]. Medicine (Baltimore),2016,95(8):e2933.
[5] Nacoti M, Cantù D, Bonacina D,et al.Heparin-like effect resistant to protamine in a child with haemorrhagic shock. Do we need heparinase?[J]. Blood Transfus,2018,16(4):394-396.
[7] Muller AD, van Doorm JM, Hemker HC, et al. Heparin-like inhibitor of blood coagulation in normal newborn[J]. Nature, 1977, 267(5612): 616-617.
[8] 赵早云. 两种全自动血凝仪的抗干扰性能的评价[J]. 血栓与止血学,2009,15(6):276-277.
Outlines

/